David Cobrinik

6.3k total citations · 1 hit paper
74 papers, 4.8k citations indexed

About

David Cobrinik is a scholar working on Molecular Biology, Oncology and Ophthalmology. According to data from OpenAlex, David Cobrinik has authored 74 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 46 papers in Oncology and 35 papers in Ophthalmology. Recurrent topics in David Cobrinik's work include Cancer-related Molecular Pathways (41 papers), Ocular Oncology and Treatments (34 papers) and Retinal Development and Disorders (10 papers). David Cobrinik is often cited by papers focused on Cancer-related Molecular Pathways (41 papers), Ocular Oncology and Treatments (34 papers) and Retinal Development and Disorders (10 papers). David Cobrinik collaborates with scholars based in United States, Switzerland and China. David Cobrinik's co-authors include Robert A. Weinberg, Nicholas J. Dyson, Tyler Jacks, Robert Hurford, Minho Lee, Jonathan Leis, David H. Abramson, Daniel S. Peeper, Peter Whyte and Xiaoliang L. Xu and has published in prestigious journals such as Nature, New England Journal of Medicine and Cell.

In The Last Decade

David Cobrinik

72 papers receiving 4.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Retinoblastoma

2015 368 citations David Cobrinik, Francis L. Munier et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Cobrinik United States	34	3.0k	2.5k	1.4k	590	510	74	4.8k
Sibylle Mittnacht United Kingdom	33	3.1k 1.0×	3.2k 1.3×	466 0.3×	487 0.8×	529 1.0×	71	5.2k
Akrit Sodhi United States	33	1.7k 0.5×	1.4k 0.6×	1.2k 0.8×	740 1.3×	189 0.4×	64	4.3k
Silvia Montaner United States	31	1.9k 0.6×	1.6k 0.6×	395 0.3×	956 1.6×	247 0.5×	60	4.2k
Maria Mudryj United States	31	2.7k 0.9×	1.9k 0.8×	272 0.2×	497 0.8×	1.0k 2.1×	63	4.3k
Aart G. Jochemsen Netherlands	34	2.8k 0.9×	2.0k 0.8×	322 0.2×	483 0.8×	391 0.8×	70	3.7k
E Harlow United States	24	4.6k 1.5×	4.7k 1.8×	561 0.4×	804 1.4×	1.4k 2.8×	29	7.1k
Liang Zhu United States	24	2.0k 0.7×	1.8k 0.7×	283 0.2×	258 0.4×	431 0.8×	46	3.0k
Didier Trouche France	36	5.1k 1.7×	1.8k 0.7×	129 0.1×	584 1.0×	613 1.2×	75	5.8k
Vladimir Bezrookove United States	28	2.1k 0.7×	1.0k 0.4×	613 0.4×	724 1.2×	333 0.7×	48	3.3k
Pradip Raychaudhuri United States	45	4.5k 1.5×	2.0k 0.8×	176 0.1×	749 1.3×	1.1k 2.1×	92	5.6k

Countries citing papers authored by David Cobrinik

Since Specialization

Citations

This map shows the geographic impact of David Cobrinik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Cobrinik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Cobrinik more than expected).

Fields of papers citing papers by David Cobrinik

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Cobrinik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Cobrinik. The network helps show where David Cobrinik may publish in the future.

Co-authorship network of co-authors of David Cobrinik

This figure shows the co-authorship network connecting the top 25 collaborators of David Cobrinik. A scholar is included among the top collaborators of David Cobrinik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Cobrinik. David Cobrinik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stachelek, Kevin, Susan Lee, Jonathan Kim, et al.. (2022). Non‐synonymous , synonymous, and non‐coding nucleotide variants contribute to recurrently altered biological processes during retinoblastoma progression. Genes Chromosomes and Cancer. 62(5). 275–289. 5 indexed citations

Li, Hongtao, Liya Xu, Daniel J. Weisenberger, et al.. (2022). Characterizing DNA methylation signatures of retinoblastoma using aqueous humor liquid biopsy. Nature Communications. 13(1). 5523–5523. 45 indexed citations

Polski, Ashley, Liya Xu, Rishvanth K. Prabakar, et al.. (2021). Comprehensive Somatic Copy Number Analysis Using Aqueous Humor Liquid Biopsy for Retinoblastoma. Cancers. 13(13). 3340–3340. 15 indexed citations

Xu, Liya, Ashley Polski, Rishvanth K. Prabakar, et al.. (2021). Establishing the Clinical Utility of ctDNA Analysis for Diagnosis, Prognosis, and Treatment Monitoring of Retinoblastoma: The Aqueous Humor Liquid Biopsy. Cancers. 13(6). 1282–1282. 42 indexed citations

Xu, Liya, Ashley Polski, Rishvanth K. Prabakar, et al.. (2020). Chromosome 6p Amplification in Aqueous Humor Cell-Free DNA Is a Prognostic Biomarker for Retinoblastoma Ocular Survival. Molecular Cancer Research. 18(8). 1166–1175. 39 indexed citations

Polski, Ashley, Liya Xu, Rishvanth K. Prabakar, et al.. (2020). Longitudinal aqueous humor sampling reflects treatment response in retinoblastoma patients. Investigative Ophthalmology & Visual Science. 61(7). 1394–1394. 4 indexed citations

Kaneva, Kristiyana, Daria Merkurjev, Dejerianne Ostrow, et al.. (2020). Detection of mitochondrial DNA variants at low level heteroplasmy in pediatric CNS and extra-CNS solid tumors with three different enrichment methods. Mitochondrion. 51. 97–103. 6 indexed citations

Singh, Hardeep, Matthew E. Thornton, Brendan H. Grubbs, & David Cobrinik. (2019). MYCN Overexpression Induces Cone Precursor Proliferation and Tumorigenesis in Explanted Retinae. Investigative Ophthalmology & Visual Science. 60(9). 1320–1320. 1 indexed citations

Munier, Francis L., Maja Beck‐Popovic, Guillermo Chantada, et al.. (2019). Conservative management of retinoblastoma: Challenging orthodoxy without compromising the state of metastatic grace. “Alive, with good vision and no comorbidity”. Progress in Retinal and Eye Research. 73. 100764–100764. 133 indexed citations

10.

Singh, Hardeep, Sijia Wang, Kevin Stachelek, et al.. (2018). Developmental stage-specific proliferation and retinoblastoma genesis in RB-deficient human but not mouse cone precursors. Proceedings of the National Academy of Sciences. 115(40). E9391–E9400. 50 indexed citations

11.

Berry, Jesse L., Liya Xu, Irsan Kooi, et al.. (2018). Genomic cfDNA Analysis of Aqueous Humor in Retinoblastoma Predicts Eye Salvage: The Surrogate Tumor Biopsy for Retinoblastoma. Molecular Cancer Research. 16(11). 1701–1712. 85 indexed citations

12.

Cobrinik, David, et al.. (2016). MDM2 but not MDM4 promotes retinoblastoma cell proliferation through p53-independent regulation of MYCN translation. Oncogene. 36(13). 1760–1769. 40 indexed citations

13.

Buckley, Jonathan D., Pedro A. Sanchez‐Lara, Dennis T. Maglinte, et al.. (2016). A Rapid and Sensitive Next-Generation Sequencing Method to Detect RB1 Mutations Improves Care for Retinoblastoma Patients and Their Families. Journal of Molecular Diagnostics. 18(4). 480–493. 25 indexed citations

14.

Singh, Hardeep, Sijia Wang, & David Cobrinik. (2015). A Human Cone Precursor Program Underlying a Proliferative Response to RB Loss. Investigative Ophthalmology & Visual Science. 56(12). 442–442. 2 indexed citations

15.

Xu, Xiaoliang L., Timothy Cardozo, Dan‐Ning Hu, et al.. (2014). Pharmacologic Targeting of Skp2 in Retinoblastoma. Investigative Ophthalmology & Visual Science. 55(13). 850–850. 1 indexed citations

16.

Aparicio, Jennifer G., et al.. (2014). Evaluation of Human Embryonic Stem Cell-Derived Retina as a Potential Retinoblastoma Model. Investigative Ophthalmology & Visual Science. 55(13). 2984–2984. 1 indexed citations

17.

Xu, Xiaoliang L., Yuqiang Fang, Thomas C. Lee, et al.. (2009). Retinoblastoma Has Properties of a Cone Precursor Tumor and Depends Upon Cone-Specific MDM2 Signaling. Cell. 137(6). 1018–1031. 175 indexed citations

18.

Xu, Xiaofei, et al.. (2008). A Cone Precursor Phenotype Distinguishes Human Retinoblastoma From Mouse Retinoblastoma Models. Investigative Ophthalmology & Visual Science. 49(13). 2012–2012.

19.

Chavala, Sai H., et al.. (2006). The MDM2 Inhibitor, Nutlin–3A, is Capable of Inhibiting Endothelial Cell Proliferation via p53 Mediated Apoptosis. Investigative Ophthalmology & Visual Science. 47(13). 5344–5344. 1 indexed citations

20.

Rossi, Ferdinando, et al.. (2000). Cdk2-dependent Phosphorylation and Functional Inactivation of the pRB-related p130 Protein in pRB(−), p16INK4A(+) Tumor Cells. Journal of Biological Chemistry. 275(39). 30317–30325. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact